Increased intercellular adhesion molecule-1 serum concentration in cholestasis

Area of Science:

• Hepatology and Immunology
• Biomarker Discovery
• Adhesion Molecule Research

Background:

• Elevated serum levels of soluble intercellular adhesion molecules (sICAM-1) are observed in cholestatic liver diseases.
• These increases are hypothesized to reflect immune system activation and inflammatory processes.
• Adhesion molecule expression is noted on bile duct epithelia and hepatocytes in cholestatic conditions.

Purpose of the Study:

• To investigate serum sICAM-1 levels in patients with primary biliary cirrhosis (PBC) and extrahepatic cholestasis.
• To compare sICAM-1 levels with established cholestasis markers (ALP, gamma-GTP, bilirubin).
• To assess the therapeutic effect of ursodeoxycholic acid (UDCA) on sICAM-1 levels and its diagnostic utility.

Main Methods:

• Serum sICAM-1 was measured using ELISA in 42 PBC patients and 18 patients with extrahepatic cholestasis.
• Levels were compared to healthy controls and correlated with histological staging and cholestasis parameters.
• ROC curve analysis determined sensitivity and specificity for predicting advanced disease stages.

Main Results:

• Significantly elevated sICAM-1 levels were found in both PBC and extrahepatic cholestasis patients compared to controls.
• sICAM-1 correlated with histological stage, ALP, bilirubin, and gamma-GTP in PBC patients.
• sICAM-1 levels above 840 µg/l predicted advanced PBC (stage III/IV) with 95% sensitivity and 85% specificity.

Conclusions:

• sICAM-1 demonstrates higher sensitivity and specificity than conventional markers for distinguishing early from advanced PBC.
• Elevated sICAM-1 in bile suggests impaired biliary elimination contributes to serum level increases.
• sICAM-1 serves as a valuable biomarker in cholestatic liver diseases, potentially indicating both synthesis and elimination issues.